BIOS Fund II NT, LP's Net Worth

Trade with PublicCompare Brokers
$0

Estimate Recalculated Sep 9, 2024 12:42AM EST

Who is BIOS Fund II NT, LP

BIOS Fund II NT, LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IN8BIO, INC., Lantern Pharma Inc., COGNITION THERAPEUTICS INC, Azitra Inc, and ACTUATE THERAPEUTICS, INC..

SEC CIK

BIOS Fund II NT, LP's CIK is 0001728851

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IN8BIO, INC.

Investor
Updated Dec 14, 2023
Form 4
—
1.72M
——
Dec 14, 2023
10.44M
Purchase
—Dec 13
Form 4
1.55%
75.00K
$2.48
$185.91K
Dec 13, 2022
8.60M
Purchase
—Dec 12
Form 4
0.52%
25.00K
$2.02
$50.54K
Sep 29, 2022
8.53M
Purchase
—Sep 28
Form 4
1.08%
51.21K
$2.02
$103.34K
Aug 30, 2022
8.50M
Purchase
—Aug 26 - Aug 29
Form 4
1.08%
51.21K
$2.02
$103.34K
Aug 30, 2022
8.50M
Purchase
—Aug 26 - Aug 29
Form 4
1.06%
50.00K
$1.93
$96.50K
Aug 18, 2022
8.45M
Purchase
—Aug 17
Form 4
69.31%
1.77M
$1.90
$3.37M
Aug 17, 2022
8.14M
Purchase
—Aug 16
Form 4
9.97%
600.63K
——
Aug 03, 2021
6.63M
Options
—Aug 03
Form 3
————
Jul 29, 2021
—
—
——
Showing 9 results

Lantern Pharma Inc.

Investor
Updated May 28, 2024
Form 4
-4.63%
-30.00K
$6.30
-$189.10K
May 28, 2024
1.23M
Sale
—May 23 - May 24
Form 4
-18.18%
-144.00K
$4.70
-$676.29K
Feb 29, 2024
1.26M
Sale
—Feb 27 - Feb 29
Form 4
-6.92%
-58.89K
$3.67
$1.93
Jan 19, 2024
1.41M
Sale
—Jan 17
Form 4
-19.78%
-145.35K
$3.44
-$500.00K
Dec 01, 2023
1.39M
Sale
—Nov 29
Form 4
-18.85%
-350.00K
$4.40
-$1.54M
Nov 09, 2022
1.53M
Sale
—Nov 08
Form 4
205.03%
58.63K
$3.12
$0.14
Sep 07, 2022
1.93M
Sell-Options
—Sep 02
Form 4
55.06%
628.63K
——
Jun 16, 2020
1.77M
Options
—Jun 15
Form 3
————
Jun 10, 2020
304.50K
—
——
Showing 8 results

COGNITION THERAPEUTICS INC

Investor
Updated Jun 11, 2024
Form 4
283.33%
17.00K
——
Jun 11, 2024
6.02M
Grant
—Jun 07
Form 4
—
500.10K
$1.05
$525.10K
Nov 13, 2023
6.01M
Grant
—Nov 08
Form 4
—
12.00K
——
Jun 13, 2023
5.51M
Grant
—Jun 09
Form 4
0.61%
16.06K
$2.65
$42.56K
Nov 29, 2022
5.50M
Purchase
—Nov 28
Form 4
2.76%
71.00K
$1.40
$99.40K
Nov 17, 2022
5.48M
Purchase
—Nov 16
Form 4
140.01%
1.50M
$1.20
$1.80M
Nov 16, 2022
5.41M
Purchase
—Nov 15
Form 4/A—
1.42M
——
Feb 01, 2022
1.42M
Options
—Oct 13
Form 3/A————
Feb 01, 2022
—
—
——
Showing 8 results

Azitra Inc

Investor
Updated Jun 23, 2023
Form 4
51.58%
2.26M
$5.00
—
Jun 23, 2023
6.74M
Purchase
—Jun 21
Form 3
————
Jun 15, 2023
669.32K
—
——
Showing 2 results

ACTUATE THERAPEUTICS, INC.

Investor
Updated Aug 20, 2024
Form 4/A
-1.74%
-25.00K
$8.00
-$199.99K
Aug 20, 2024
1.41M
Sale
—Aug 14
Form 4
————
Aug 14, 2024
231.38K
—
——
Form 4
5.20%
490.00K
$7.68
$775.01K
Aug 14, 2024
9.98M
Purchase
—Aug 12 - Aug 14
Form 3
————
Aug 12, 2024
231.38K
—
——
Showing 4 results
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved